As well as a high level of expression in NBs, ASCL1 levels were also elevated in other neural-based tumours (glioma and ependymoma), whereas other tumour types showed lower levels (Fig. 4B) (Rheinbay et al., 2013). This evidence concerns the gene ASCL1 and central nervous system cancer.